Wird geladen...

Enzyme replacement therapy for Fabry disease: A systematic review and meta-analysis

The specific treatment available for Fabry disease (FD) is enzyme replacement therapy (ERT) with agalsidase alfa or beta. A systematic review and meta-analysis was conducted to assess the efficacy and safety of ERT for FD. Only double-blind, randomized clinical trials (RCTs) comparing agalsidase alf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Alegra, Taciane, Vairo, Filippo, de Souza, Monica V., Krug, Bárbara C., Schwartz, Ida V.D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Sociedade Brasileira de Genética 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3571424/
https://ncbi.nlm.nih.gov/pubmed/23413206
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!